Welcome to CDC Stacks | Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy - 41002 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy
  • Published Date:
    Jun 30 2016
  • Source:
    Circ Res. 119(5):635-651.


Public Access Version Available on: August 19, 2017 information icon
Please check back on the date listed above.
Details:
  • Pubmed ID:
    27364016
  • Pubmed Central ID:
    PMC4992406
  • Funding:
    H75 DP424252/DP/NCCDPHP CDC HHS/United States
    P01 HL078825/HL/NHLBI NIH HHS/United States
    R01 HL055757/HL/NHLBI NIH HHS/United States
    R01 HL068088/HL/NHLBI NIH HHS/United States
    R01 HL074351/HL/NHLBI NIH HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Rationale

    The effects of c-kitPOS cardiac progenitor cells (CPCs) (and adult cell therapy in general) on left ventricular (LV) function have been regarded as modest or inconsistent.

    Objective

    To determine whether three CPC infusions have greater efficacy than one infusion.

    Methods and Results

    Rats with a 30-day-old myocardial infarction received one or three CPC infusions into the LV cavity, 35 days apart. Compared with vehicle-treated rats, the single-dose group exhibited improved LV function after the 1st infusion (consisting of CPCs) but not after the 2nd and 3rd (vehicle). In contrast, in the multiple-dose group regional and global LV function improved by a similar degree after each CPC infusion, resulting in greater cumulative effects. For example, the total increase in LV ejection fraction was approximately triple in the multiple-dose group vs. the single-dose group (P<0.01). The multiple-dose group also exhibited more viable tissue and less scar, less collagen in the risk and noninfarcted regions, and greater myocyte density in the risk region.

    Conclusions

    This is the first demonstration that repeated CPC administrations are markedly more effective than a single administration. The concept that the full effects of CPCs require repeated doses has significant implications for both preclinical and clinical studies; it suggests that the benefits of cell therapy may be underestimated or even overlooked if they are measured after a single dose, and that repeated administrations are necessary to properly evaluate the effectiveness of a cell product. In addition, we describe a new method that enables studies of repeated cell administrations in rodents.

  • Supporting Files:
    No Additional Files